Psilocybin rTMS for Treatment Resistant Depression

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 10, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2030

Conditions
Treatment Resistant DepressionMDDMajor Depressive DisorderRecurrent DepressionDepression
Interventions
DRUG

Psilocybin

A psychedelic drug found in certain mushrooms. It will be in a capsule of 25mg psilocybin (COMP360).

DEVICE

Accelerated intermittent theta burst (aiTBS) rTMS treatment

A form of non-invasive brain stimulation that delivers a series of quick magnetic pulses to the scalp and a portion of the brain. It will be targeted to a functional magnetic resonance imaging (fMRI) functional connectivity-guided personalized left dorsolateral prefrontal cortex target using neuronavigation and delivered over 10 sessions daily for 5 consecutive days at 90% of coil-to-target depth-corrected resting motor threshold.

DRUG

Low-dose psilocybin

A psychedelic drug found in certain mushrooms. It will be in a low-dose form of the experimental dose as a 1mg capsule of psilocybin (COMP360).

DEVICE

Sham Accelerated intermittent theta burst (aiTBS) rTMS treatment

The sham version is meant to look and feel like the active SAINT rTMS, but the main difference is that the brain is not being stimulated like the active condition.

Trial Locations (1)

78712

RECRUITING

Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600, Austin

All Listed Sponsors
lead

University of Texas at Austin

OTHER